rs181058279

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_080424.4(SP110):​c.2122G>C​(p.Gly708Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000892 in 1,612,512 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G708S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00093 ( 3 hom. )

Consequence

SP110
NM_080424.4 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: -0.471

Publications

7 publications found
Variant links:
Genes affected
SP110 (HGNC:5401): (SP110 nuclear body protein) The nuclear body is a multiprotein complex that may have a role in the regulation of gene transcription. This gene is a member of the SP100/SP140 family of nuclear body proteins and encodes a leukocyte-specific nuclear body component. The protein can function as an activator of gene transcription and may serve as a nuclear hormone receptor coactivator. In addition, it has been suggested that the protein may play a role in ribosome biogenesis and in the induction of myeloid cell differentiation. Alternative splicing has been observed for this gene and three transcript variants, encoding distinct isoforms, have been identified. [provided by RefSeq, Jul 2008]
SP110 Gene-Disease associations (from GenCC):
  • hepatic veno-occlusive disease-immunodeficiency syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, ClinGen, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013007194).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000493 (75/152074) while in subpopulation NFE AF = 0.000839 (57/67976). AF 95% confidence interval is 0.000664. There are 0 homozygotes in GnomAd4. There are 30 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_080424.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
NM_080424.4
MANE Select
c.2122G>Cp.Gly708Arg
missense
Exon 19 of 19NP_536349.3Q9HB58-6
SP110
NM_001378442.1
c.2218G>Cp.Gly740Arg
missense
Exon 20 of 20NP_001365371.1
SP110
NM_001378443.1
c.2200G>Cp.Gly734Arg
missense
Exon 19 of 19NP_001365372.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SP110
ENST00000258381.11
TSL:2 MANE Select
c.2122G>Cp.Gly708Arg
missense
Exon 19 of 19ENSP00000258381.6Q9HB58-6
SP110
ENST00000358662.9
TSL:1
c.2050G>Cp.Gly684Arg
missense
Exon 18 of 18ENSP00000351488.4Q9HB58-1
SP110
ENST00000897327.1
c.2050G>Cp.Gly684Arg
missense
Exon 19 of 19ENSP00000567386.1

Frequencies

GnomAD3 genomes
AF:
0.000494
AC:
75
AN:
151956
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000525
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000838
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000378
AC:
95
AN:
251420
AF XY:
0.000390
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.000723
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000554
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000933
AC:
1363
AN:
1460438
Hom.:
3
Cov.:
29
AF XY:
0.000877
AC XY:
637
AN XY:
726616
show subpopulations
African (AFR)
AF:
0.000149
AC:
5
AN:
33458
American (AMR)
AF:
0.000693
AC:
31
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53390
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00117
AC:
1297
AN:
1110716
Other (OTH)
AF:
0.000497
AC:
30
AN:
60342
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
56
111
167
222
278
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000493
AC:
75
AN:
152074
Hom.:
0
Cov.:
31
AF XY:
0.000404
AC XY:
30
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41482
American (AMR)
AF:
0.000524
AC:
8
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10578
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000839
AC:
57
AN:
67976
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000721
Hom.:
0
Bravo
AF:
0.000487
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ExAC
AF:
0.000264
AC:
32
EpiCase
AF:
0.000491
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
-
Hepatic veno-occlusive disease-immunodeficiency syndrome (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.3
DANN
Benign
0.75
DEOGEN2
Benign
0.0017
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.47
T
M_CAP
Benign
0.0044
T
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.47
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.045
Sift
Benign
0.082
T
Sift4G
Benign
0.094
T
Polyphen
0.013
B
Vest4
0.16
MVP
0.23
MPC
0.65
ClinPred
0.027
T
GERP RS
-5.2
Varity_R
0.047
gMVP
0.17
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181058279; hg19: chr2-231033860; COSMIC: COSV51275354; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.